Genentech, a member of the Roche Group, has more than 40 years of experience in the field of biotechnology.
Regeneron is a leading biotechnology company that invents life-transforming medicines for serious diseases.
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face.
REGENXBIO Inc. is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Our gene therapy product candidates are designed to deliver functional genes, enabling the production of therapeutic proteins or antibodies that are intended to impact disease.
Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs.
Eyenuk, Inc. is a global artificial intelligence (AI) digital health company and the leader in real-world AI Eye Screening™ for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance.
If you are interested in sponsoring the Ophthalmic Artificial Intelligence meeting, please contact us at events@ivistameded.com or at +1-559-281-3257.
This event is provided by iVista Medical Education, Inc. | events@ivistameded.com | www.ivistamedicaleducation.com
